GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

The probability of revision sinus surgery including removing nasal polyps is higher if the patient has asthma or is on ...

Low vitamin D in patients with nasal polyps negatively correlated with several markers, including Lund-Mackay and total nasal polyp scores. “Recently, the role of vitamin D in the development of ...

GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.29 billion and currently ...

This could potentially transform treatment paradigms by reducing the ... effectively reduced the size and obstruction of nasal polyps compared to placebo. Kaivan Khavandi, SVP, Global Head of ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

The inclusion criteria for patients were: (a) met the diagnostic criteria of the “European Position Paper on Rhinosinusitis and Nasal Polyps 2020”; (b) aged ≥18 years; (c) no relevant medication ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...

GSK plc (LSE/NYSE: GSK) today announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, ...

It also explains the association between gallbladder polyps and cancer and looks at the treatment options. Share on Pinterest An ultrasound view of the gallbladder showing a polyp inside it.